NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- E-Star BioTech, LLC (“E-Star” or the “Company”), an innovative developer of novel peptides designed to treat cardiovascular, metabolic, and kidney diseases ...

Clinical and translational research projects are a focus of the cardiology division, and the faculty have been active in producing abstracts accepted for regional and national presentations as well as ...

March 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced five presentations related to aficamten, an investigational cardiac myosin inhibitor, and hypertrophic ...

Late Breaker Oral Presentation to Include New Data from Cohort 1 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201SOUTH ...

today announced its presentation of clinical trial results at the 2025 Annual Meeting of the American College of Cardiology. The presentation, “Differential Response Between African Americans ...

Building on early encouraging data shared in December 2024, the presentation at ACC will include results from one-year assessments of the first two patients to receive TN-201 gene therapy ...

Late Breaker Oral Presentation to Include New Data from Cohort 1 of the ... program will be presented at the upcoming American College of Cardiology's Annual Scientific Session being held March 29-31, ...